Breaking News

Thermo Fisher Continues Expansion to Support COVID-19 Response

BARDA provides funding to support the expansion of Thermo Fisher's manufacturing capacity for sterile injectables.

By: Contract Pharma

Contract Pharma Staff

Thermo Fisher Scientific Inc. continues to expand global capacity and capabilities across its pharma services network to support government, industry and academia as they accelerate development and production of COVID-19 vaccines, therapies and other treatments. The company is now supporting more than 200 of these projects globally. In the U.S., the Biomedical Advanced Research and Development Authority (BARDA), announced funding to support the expansion of Thermo Fisher’s manufacturin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters